Some patients with coronavirus disease 2019 (COVID-19) show abnormal changes in laboratory myocardial injury markers, suggesting that patients with myocardial injury have a higher mortality rate than those without myocardial injury. This article reviews the possible mechanism of myocardial injury in patients with COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the patients with COVID-19 in aspects of direct infection of myocardial injury, specific binding to functional receptors on cardiomyocytes, and immune-mediated myocardial injury. During hospitalization, the monitoring of laboratory myocardial injury markers in patients of COVID-19 should be strengthened.
All Keywords
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, coronavirus, Hospitalization, Laboratory, myocardial injury, Patient, mortality rate, mechanism, binding, Immune-mediated, marker, acute respiratory syndrome, direct infection, Affect, the patient, abnormal change, functional receptor, patients of COVID-19, patients with COVID-19, with COVID-19, 【제목키워드】 change, cardiac,
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, coronavirus, Hospitalization, Laboratory, myocardial injury, Patient, mortality rate, mechanism, binding, Immune-mediated, marker, acute respiratory syndrome, direct infection, Affect, the patient, abnormal change, functional receptor, patients of COVID-19, patients with COVID-19, with COVID-19, 【제목키워드】 change, cardiac,